Jundishapur Journal of Microbiology

Published by: Kowsar

The Role of Isocitrate Lyase (ICL1) in the Metabolic Adaptation of Candida albicans Biofilms

Oluwaseun Ayodeji Ishola 1 , Seng Yeat Ting 1 , Yasser M Tabana 1 , Mowaffaq Adam Ahmed 1 , Muhammad Amir Yunus 1 , Rafeezul Mohamed 2 , Leslie Thian Lung Than 3 and Doblin Sandai 1 , *
Authors Information
1 Infectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia
2 Regenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia
3 Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
Article information
  • Jundishapur Journal of Microbiology: September 01, 2016, 9 (9); e38031
  • Published Online: August 30, 2016
  • Article Type: Research Article
  • Received: March 24, 2016
  • Revised: August 14, 2016
  • Accepted: August 19, 2016
  • DOI: 10.5812/jjm.38031

To Cite: Ishola O A, Ting S Y, Tabana Y M, Ahmed M A, Yunus M A, et al. The Role of Isocitrate Lyase (ICL1) in the Metabolic Adaptation of Candida albicans Biofilms, Jundishapur J Microbiol. 2016 ; 9(9):e38031. doi: 10.5812/jjm.38031.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis. 2004; 10(1): 14-9[DOI][PubMed]
  • 2. Calderone R, Gow NA. Host recognition by Candida species. 2002; : 67-86
  • 3. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013; 62: 10-24[DOI][PubMed]
  • 4. Ramage G, Rajendran R, Sherry L, Williams C. Fungal biofilm resistance. Int J Microbiol. 2012; 2012: 528521[DOI][PubMed]
  • 5. Brown A, Argimon S, Gow N. Signal transduction and morphogenesis in Candida albicans. 2007; : 167-94
  • 6. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryot Cell. 2005; 4(4): 633-8[DOI][PubMed]
  • 7. Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol. 2002; 19(3): 139-43[PubMed]
  • 8. Pfaller M, Jones R, Messer S, Edmond M, Wenzel R. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis. 1998; 31(1): 327-32[PubMed]
  • 9. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012; 4(165): 165[DOI][PubMed]
  • 10. Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol. 2011; 9(2): 109-18[DOI][PubMed]
  • 11. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res. 2001; 80(3): 903-8[PubMed]
  • 12. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003; 11(1): 30-6[PubMed]
  • 13. Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, et al. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 2012; 8(8): 1002848[DOI][PubMed]
  • 14. Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis. 2010; 202(1): 171-5[DOI][PubMed]
  • 15. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol. 1999; 48(7): 671-9[DOI][PubMed]
  • 16. Sardi JC, Almeida AM, Mendes Giannini MJ. New antimicrobial therapies used against fungi present in subgingival sites--a brief review. Arch Oral Biol. 2011; 56(10): 951-9[DOI][PubMed]
  • 17. Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis. 2002; 21(11): 767-74[DOI][PubMed]
  • 18. Bink A, Pellens K, Cammue PAB, Thevissen K. Anti-biofilm strategies: how to eradicate Candida biofilms? Open Mycol J. 2011; 5(1): 29-38[DOI]
  • 19. Barelle CJ, Priest CL, Maccallum DM, Gow NA, Odds FC, Brown AJ. Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol. 2006; 8(6): 961-71[DOI][PubMed]
  • 20. Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat Protoc. 2008; 3(12): 1909-24[DOI][PubMed]
  • 21. Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008; 3(9): 1494-500[DOI][PubMed]
  • 22. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother. 1995; 39(9): 2128-31[PubMed]
  • 23. Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, Hoyer LL. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology. 2004; 150: 267-75[DOI][PubMed]
  • 24. Lorenz MC, Fink GR. The glyoxylate cycle is required for fungal virulence. Nature. 2001; 412(6842): 83-6[DOI][PubMed]
  • 25. Lorenz MC, Bender JA, Fink GR. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell. 2004; 3(5): 1076-87[DOI][PubMed]
  • 26. Piekarska K, Mol E, van den Berg M, Hardy G, van den Burg J, van Roermund C, et al. Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans. Eukaryot Cell. 2006; 5(11): 1847-56[DOI][PubMed]
  • 27. Sandai D, Yin Z, Selway L, Stead D, Walker J, Leach MD, et al. The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans. MBio. 2012; 3(6)[DOI][PubMed]
  • 28. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 2009; 7(6): 1000133[DOI][PubMed]
  • 29. Ramirez MA, Lorenz MC. Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypes. Eukaryot Cell. 2007; 6(2): 280-90[DOI][PubMed]
  • 30. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother. 2007; 51(2): 510-20[DOI][PubMed]
  • 31. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002; 46(6): 1773-80[PubMed]
  • 32. Nailis H, Vandenbosch D, Deforce D, Nelis HJ, Coenye T. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Res Microbiol. 2010; 161(4): 284-92[DOI][PubMed]
  • 33. Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002; 49(6): 973-80[PubMed]
  • 34. Watamoto T, Samaranayake LP, Egusa H, Yatani H, Seneviratne CJ. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals. J Med Microbiol. 2011; 60: 1241-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments